Besremi Pen Injection, Solution
Product Images NDC 73536-511

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 34 technical images submitted to the FDA as part of the official labeling for Besremi Pen (NDC 73536-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmaessentia Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure A (Besremi 01)

Figure A (Besremi 01)
This appears to be a diagram or image with labels of a medical syringe. The labels indicate the textured collar, the body of the syringe with dose lines, a clear needle cap, a gray stopper, a finger flange, and the plunger. No further information can be gathered from this output.*
FDA Label Image

Figure B (Besremi 02)

Figure B (Besremi 02)
FDA Label Image

Figure C & D (Besremi 03)

Figure C & D (Besremi 03)
This text provides instructions on how to adjust the medicine level for a prescribed dose using a syringe with specific markings. It highlights the importance of aligning the top outer edge of the gray stopper with the correct dose line on the syringe, rather than the dome at the top of the stopper. Two examples of different prescribed doses are given as a visual reference.*
FDA Label Image

Figure E (Besremi 04)

Figure E (Besremi 04)
FDA Label Image

Figure F (Besremi 05)

Figure F (Besremi 05)
FDA Label Image

Figure G (Besremi 06)

Figure G (Besremi 06)
FDA Label Image

Figure H (Besremi 07)

Figure H (Besremi 07)
FDA Label Image

Figure I (Besremi 08)

Figure I (Besremi 08)
FDA Label Image

Figure J (Besremi 09)

Figure J (Besremi 09)
FDA Label Image

Figure K (Besremi 10)

Figure K (Besremi 10)
FDA Label Image

Figure L (Besremi 11)

Figure L (Besremi 11)
FDA Label Image

Figure M (Besremi 12)

Figure M (Besremi 12)
FDA Label Image

Figure N (Besremi 13)

Figure N (Besremi 13)
FDA Label Image

Figure O (Besremi 14)

Figure O (Besremi 14)
FDA Label Image

Figure P (Besremi 15)

Figure P (Besremi 15)
FDA Label Image

Figure Q (Besremi 16)

Figure Q (Besremi 16)
FDA Label Image

Figure R (Besremi 17)

Figure R (Besremi 17)
FDA Label Image

Figure S (Besremi 18)

Figure S (Besremi 18)
FDA Label Image

Figure T (Besremi 19)

Figure T (Besremi 19)
FDA Label Image

Figure U (Besremi 20)

Figure U (Besremi 20)
FDA Label Image

Figure V (Besremi 21)

Figure V (Besremi 21)
FDA Label Image

Figure W (Besremi 22)

Figure W (Besremi 22)
FDA Label Image

Figure X (Besremi 23)

Figure X (Besremi 23)
FDA Label Image

Figure Y (Besremi 24)

Figure Y (Besremi 24)
FDA Label Image

Figure Z (Besremi 25)

Figure Z (Besremi 25)
FDA Label Image

Figure Aa (Besremi 26)

Figure Aa (Besremi 26)
FDA Label Image

Figure Ab (Besremi 27)

Figure Ab (Besremi 27)
FDA Label Image

Figure Ac (Besremi 28)

Figure Ac (Besremi 28)
FDA Label Image

Figure Ad (Besremi 29)

Figure Ad (Besremi 29)
FDA Label Image

Figure Ae (Besremi 30)

Figure Ae (Besremi 30)
FDA Label Image

Figure Af (Besremi 31)

Figure Af (Besremi 31)
FDA Label Image

Figure Ag (Besremi 32)

Figure Ag (Besremi 32)
FDA Label Image

Principal Display Panel (500 mcg/mL Syringe Label)

Principal Display Panel (500 mcg/mL Syringe Label)
This appears to be the label of a medication called "ropeginterferonalfa-2o-njt". It comes in a concentration of 500 meg/mL and is intended for subcutaneous use only. The label also shows a prescription number and the name of the manufacturer, PharmaEssentia Corp.*
FDA Label Image

Principal Display Panel (500 mcg/mL Syringe Carton)

Principal Display Panel (500 mcg/mL Syringe Carton)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.